Back
  1. Home
  3. Detailled Reference
Request a copy
Paper published in a journal (Scientific congresses and symposiums)
132MO Molecular profiling of 991 prospectively recruited rare cancers patients in EUROPE: First results of ARCAGEN – an EORTC-SPECTA and EURACAN study
Morfouace, M.; Oliveira, J.; Penel, N. et al.
2023 • In Annals of Oncology, 34, p. 233-S234
Peer Reviewed verified by ORBi
Permalink
https://hdl.handle.net/2268/308605
DOI
10.1016/j.annonc.2023.09.2857
 

Files (1)Send toDetailsStatisticsBibliographySimilar publications

Files

Full Text
Molecular profiling of 991 prospectively recruited rare cancers patients in EUROPE.pdf
Author postprint (190.01 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to


Details


Keywords :
Oncology; Hematology
Disciplines :
Oncology
Author, co-author :
Morfouace, M.
Oliveira, J.
Penel, N.
Peron, J.
Pracht, M.
Brasiuniene, B.
Capela Marques, A.
Gennigens, Christine  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service d'oncologie médicale
Greillier, L.
Robert, M-S.
Klumpen, H.J.
Peeters, R.
Licitra, L.F.L.
Girard, N.
Gietema, J.A.
de Herder, W.
Kapiteijn, E.
Idbaih, A.
Ray-Coquard, I.L.
Blay, J-Y.
More authors (10 more) Less
Language :
English
Title :
132MO Molecular profiling of 991 prospectively recruited rare cancers patients in EUROPE: First results of ARCAGEN – an EORTC-SPECTA and EURACAN study
Publication date :
October 2023
Event name :
ESMO Congress 2023
Event place :
Madrid, Spain
Event date :
20-24 October 2023
Audience :
International
Journal title :
Annals of Oncology
ISSN :
0923-7534
eISSN :
1569-8041
Publisher :
Elsevier BV
Volume :
34
Pages :
S233-S234
Peer reviewed :
Peer Reviewed verified by ORBi
Additional URL :
https://api.elsevier.com/content/article/PII:S0923753423036943?httpAccept=text/xml
Available on ORBi :
since 10 November 2023

Statistics

Number of views
17 (7 by ULiège)
Number of downloads
0 (0 by ULiège)
More statistics

Bibliography

Similar publications


Contact ORBi